Stresscopins and their uses

Details Stresscopins and their uses Stresscopins and their uses

2007-11-06

2007-11-06

Li, Ruixiang (Department: 1646)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Hormone or other secreted growth regulatory factor,...

C514S012200

Reexamination Certificate

active

10682794

ABSTRACT:
The invention provides novel nucleic acids and polypeptides, referred to herein as stresscopin 1 and stresscopin 2, which preferentially activate the CRH-R2 receptor over the R1 receptor. Stresscopins, analogs and mimetics, and related CRH-R2 agonists suppress food intake and heat-induced edema; but do not induce substantial release of ACTH. Stresscopin also finds use in the recovery phase of stress responses, as an anti-inflammatory agent, as a hypotensive agent, as a cardioprotective agent, and in the treatment of psychiatric and anxiolytic disorders. Stresscopin nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways.

REFERENCES:
patent: 2003/0036507 (2003-02-01), Vale et al.
patent: 2004/0143095 (2004-07-01), Vale et al.
patent: WO-200212307 (2002-02-01), None
Hsu et al., Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. 7 (5):605-611, May 2001.
Lewis et al., Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A. 98:7570-7575, 2001.
Shibahara, S. et al. Isolation and sequence analysis of the human corticotropin-releasing factor precurser gene, The EMBO Journal (vol. 2 No. 5 pp. 775-779, 1983).
Donaldson, CJ et al. Cloning and Characterization of Human Urocortin, Endocrinology (137:2167-2170, 1996).
Chen, R. et al. Expression cloning of a human corticotropin-releasing-factor receptor, (Proc. Natl. Acad. Sci. USA, vol. 90, pp. 8967-8971, Oct. 1993).
Liaw, C.W. et al. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid, (Dept. of Molecular Neurobiology, Neurocrine Biosciences, Inc., San Diego, CA;Genbank/U34587, PMID:8536644, PubMed-indexed for Medline).
Grammatopoulos, D.K. et al. A Novel Spliced Variant of the Type 1 Corticotropin-Releasing Hormone Receptor with a Deletion in the Seventh Transmembrane Domain Present in the Human Pregnant Term Myometrium and Fetal Membranes, (Molecular Endocrinology, vol. 13 No. 12, The Endocrine Society, pp. 2189-2202, 1999).
Smith, G.W. et al. Corticotropin Releasing Factor Receptor 1-Deficient Mice Display Decreased Anxiety, Impaired Stress Response, and Aberrant Neuroendocrine Development, (Cell Press, Neuron, vol. 20,1093-1102, Jun. 1998).
Bale, T.L. et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress, (Nature Genetics, Letter, vol. 24, pp. 410-414, Apr. 2000).
Coste, S.C. et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2, (Nature Genetics, Letter, vol. 24, pp. 403-409, Apr. 2000).
Reyes et al., Urocortin II: A Member of the Corticotropin-Releasing Factor (CRF) Neuropeptide Family that is Selectively Bound By Type 2 CRF Receptors, PNAS, 2001, 98(5): 2843-2848.

Affiliated with

Also associated with

Rating

Stresscopins and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stresscopins and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stresscopins and their uses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3882081